HSBC Holdings’s Guardant Health GH Stock Holding History

HSBC Holdings’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,300	Closed	-$131K	–	3333
2021 Q4	$131K	Buy	+1,300	New	+$134K	﹤0.01%	3109

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's GH Position: Q1 2026 in Review

HSBC Holdings increased its Guardant Health (GH) stake by 1,070% in Q1 2026, buying an estimated $9.08M and bringing the position to 98,843 shares worth $9.13M. The position accounts for ﹤0.01% of the portfolio, ranked #959.

HSBC Holdings first reported a position in GH in Q3 2020 and has held it in 22 quarters since. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

HSBC Holdings held 98,843 shares of Guardant Health worth $9.13M as of Q1 2026.
HSBC Holdings bought 90,392 Guardant Health shares in Q1 2026, an estimated $9.08M.
Guardant Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #959 holding.
HSBC Holdings first reported a position in Guardant Health in Q3 2020 and has held it in 22 quarters since.
482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.